NCT03419832

Brief Summary

There is evidence that the current design and content provided by most biomedical research informed consent documents do not consistently meet the expectations researchers place on them to effectively inform research participants of information thought to be most important in facilitating their ability to make informed decisions about participation. The need for revisions to the informed consent document design is supported by empirical research.This pilot study will examine the effectiveness of the New Executive and Appendix Template (NEAT) form when used in the consent process for individuals participating in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 5, 2018

Completed
5.7 years until next milestone

Results Posted

Study results publicly available

October 13, 2023

Completed
Last Updated

October 13, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

January 22, 2018

Results QC Date

September 20, 2023

Last Update Submit

September 20, 2023

Conditions

Keywords

ARIC

Outcome Measures

Primary Outcomes (1)

  • Comprehension of the NEAT Form

    Following the consent process, participants will be administered the Comprehension tool to measure their comprehension. The summary scores will be used to address the primary aim of whether or not the NEAT consent form improves participant comprehension. There are 7 questions, each question is rated 0-2 with a total scale of 0-14. Higher values denotes better outcomes.

    at visit one, up to 24 hours

Secondary Outcomes (4)

  • Qualitative Analysis of the Readability and Understandability of the Consent Form by Participants

    at visit one, up to 24 hours

  • Qualitative Analysis of the Format and Design of the Consent Form by Participants

    at visit one, up to 24 hours

  • Qualitative Analysis of the Time of Discussion of the Consent Form by Participants

    at visit one, up to 24 hours

  • Qualitative Analysis of the Format and Design of the Consent Form by Study Team

    at visit one, up to 24 hours

Study Arms (2)

NEAT Form

EXPERIMENTAL

Study participants will be randomized to the NEAT form and the materials that accompany it (also detailing the ARIC study).

Other: NEAT Form

Standard Form

ACTIVE COMPARATOR

Study participants will be randomized to the traditional standard consent form (detailing the ARIC study).

Other: Standard Form

Interventions

The NEAT form consists of a clear and concise overview document containing information satisfying all elements of consent. This is made up of IRB-approved wording from the regular consent form. More detailed information, such as specific clinic measures are provided as additional material and are discussed during the consent process after the general overview has been provided with the NEAT form.

NEAT Form

The regular IRB approved version.

Standard Form

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Individuals who are eligible for the ARIC study, with which this pilot study is cooperating.

You may not qualify if:

  • Any individuals not eligible for the ARIC study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

Location

Results Point of Contact

Title
Joseph E. Andrews, Jr., PhD, CIP, CCRP
Organization
Wake Forest School of Medicine

Study Officials

  • Joseph Andrews, PhD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2018

First Posted

February 5, 2018

Study Start

April 4, 2017

Primary Completion

May 23, 2017

Study Completion

May 23, 2017

Last Updated

October 13, 2023

Results First Posted

October 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations